- Home
- BCAL vs EBS Comparison
BCAL vs EBS Comparison
Compare BCAL & EBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BCAL | EBS |
|---|---|---|
| Founded | 2001 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 616.3M | 595.6M |
| IPO Year | 2020 | 2006 |
Fundamental Metrics
Financial Performance| Metric | BCAL | EBS |
|---|---|---|
| Price | $18.43 | $8.97 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | ★ $20.50 | $15.00 |
| AVG Volume (30 Days) | 181.2K | ★ 911.1K |
| Earning Date | 01-01-0001 | 05-27-2026 |
| Dividend Yield | ★ 2.18% | N/A |
| EPS Growth | N/A | ★ 125.83 |
| EPS | ★ 1.42 | 0.93 |
| Revenue | N/A | ★ $742,900,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $6.35 | $15.21 |
| P/E Ratio | $12.92 | ★ $9.54 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $11.88 | $4.02 |
| 52 Week High | $20.47 | $14.06 |
Technical Indicators
Market Signals| Indicator | BCAL | EBS |
|---|---|---|
| Relative Strength Index (RSI) | 44.06 | 31.85 |
| Support Level | $17.80 | $5.89 |
| Resistance Level | $19.31 | $9.68 |
| Average True Range (ATR) | 0.43 | 0.60 |
| MACD | -0.06 | -0.21 |
| Stochastic Oscillator | 42.99 | 27.81 |
Price Performance
Historical ComparisonAbout BCAL Southern California Bancorp
California BanCorp is a registered bank holding company headquartered in San Diego, California. The Bank offers a range of financial products and services to individuals, professionals, and small to medium-sized businesses through its 14 branch offices and four loan production offices serving Northern and Southern California. The Bank's solutions-driven, relationship-based approach to banking provides accessibility to decision-makers and enhances value through partnerships with its clients. The company has one operating segment: Commercial Banking.
About EBS Emergent Biosolutions Inc.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.